Organon (OGN) Enterprise Value (2020 - 2026)

Organon (OGN) recorded quarterly Enterprise Value of -$1.1 billion in Q1 2026, down 94.43% quarter-over-quarter from -$574.0 million in Q4 2025, and down 104.02% on a YoY basis from $27.7 billion in Q1 2025.

Organon (OGN) Enterprise Value (2020 - 2026) Analysis & Trends

Organon's Enterprise Value history runs 7 years deep, the most recent figure standing at -$1.1 billion for Q1 2026.

  • In Q1 2026, Enterprise Value fell 104.02% year-over-year to -$1.1 billion; the TTM figure through Mar 2026 stood at -$1.1 billion (down 104.02% YoY), while the FY2025 annual figure was -$574.0 million, up 18.47% from the prior year.
  • Enterprise Value was -$1.1 billion for Q1 2026 at Organon, down from -$574.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$326.0 million in Q2 2023 to a low of -$1.1 billion in Q1 2026.
  • Historically, Enterprise Value has averaged -$623.5 million across 5 years, with a median of -$599.0 million in 2025.
  • Biggest YoY gain for Enterprise Value was 50.5% in 2022; the steepest drop was 392.2% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$706.0 million in 2022, then rose by 0.57% to -$702.0 million in 2023, then retreated by 0.28% to -$704.0 million in 2024, then gained by 18.47% to -$574.0 million in 2025, then slumped by 94.43% to -$1.1 billion in 2026.
  • The last three Enterprise Value figures came in at -$1.1 billion (Q1 2026), -$574.0 million (Q4 2025), and -$672.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn -4.96 Bn
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn -5.28 Bn
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn -22.05 Bn
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn -9.35 Bn
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn -5.65 Bn
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn -12.04 Bn
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn -7.73 Bn
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn -12.77 Bn
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn -10.45 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn -1.12 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.12 Bn
Dec 31, 2025 -574.00 Mn
Sep 30, 2025 -672.00 Mn
Jun 30, 2025 -599.00 Mn
Mar 31, 2025 -547.00 Mn
Dec 31, 2024 -704.00 Mn
Sep 30, 2024 -763.00 Mn
Jun 30, 2024 -704.00 Mn
Mar 31, 2024 -575.00 Mn
Dec 31, 2023 -702.00 Mn
Sep 30, 2023 -414.00 Mn
Jun 30, 2023 -326.00 Mn
Mar 31, 2023 -459.00 Mn
Dec 31, 2022 -706.00 Mn
Sep 30, 2022 -499.00 Mn
Jun 30, 2022 -545.00 Mn
Mar 31, 2022 -694.00 Mn
Dec 31, 2021 -737.00 Mn
Sep 30, 2021 -1.01 Bn
Jun 30, 2021 -730.00 Mn